Literature DB >> 12684441

Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons.

Deborah C Mash1, Qinjie Ouyang, John Pablo, Margaret Basile, Sari Izenwasser, Abraham Lieberman, Richard J Perrin.   

Abstract

Alpha-synuclein is a presynaptic protein that has been implicated as a possible causative agent in the pathogenesis of Parkinson's disease. The native protein is a major component of nigral Lewy bodies in Parkinson's disease, and full-length alpha-synuclein accumulates in Lewy neurites. Here we present evidence that alpha-synuclein levels are elevated in midbrain dopamine (DA) neurons of chronic cocaine abusers. Western blot and immunoautoradiographic studies were conducted on postmortem neuropathological specimens from cocaine users and age-matched drug-free control subjects. The results demonstrated that alpha-synuclein levels in the DA cell groups of the substantia nigra/ventral tegmental complex were elevated threefold in chronic cocaine users compared with normal age-matched subjects. The increased protein levels in chronic cocaine users were accompanied by changes in the expression of alpha-synuclein mRNA in the substantia nigra and ventral tegmental area. Although alpha-synuclein expression is prominent in the hippocampus, there was no increase in protein expression in this brain region. The levels of beta-synuclein, a possible negative regulator of alpha-synuclein, also were not affected by cocaine exposure. Alpha-synuclein protein levels were increased in the ventral tegmental area, but not the substantia nigra, in victims of excited cocaine delirium who experienced paranoia, marked agitation, and hyperthermia before death. The overexpression of alpha-synuclein may occur as a protective response to changes in DA turnover and increased oxidative stress resulting from cocaine abuse. However, the accumulation of alpha-synuclein protein with long-term cocaine abuse may put addicts at increased risk for developing the motor abnormalities of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684441      PMCID: PMC6742069     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

Review 1.  Synucleins in synaptic plasticity and neurodegenerative disorders.

Authors:  D F Clayton; J M George
Journal:  J Neurosci Res       Date:  1999-10-01       Impact factor: 4.164

2.  A measure of striatal function predicts motor stereotypy.

Authors:  J J Canales; A M Graybiel
Journal:  Nat Neurosci       Date:  2000-04       Impact factor: 24.884

3.  MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons.

Authors:  N W Kowall; P Hantraye; E Brouillet; M F Beal; A C McKee; R J Ferrante
Journal:  Neuroreport       Date:  2000-01-17       Impact factor: 1.837

Review 4.  Cytotoxic and genotoxic potential of dopamine.

Authors:  A H Stokes; T G Hastings; K E Vrana
Journal:  J Neurosci Res       Date:  1999-03-15       Impact factor: 4.164

5.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

6.  Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury.

Authors:  N G Kholodilov; M Neystat; T F Oo; S E Lo; K E Larsen; D Sulzer; R E Burke
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

7.  Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.

Authors:  S M Solano; D W Miller; S J Augood; A B Young; J B Penney
Journal:  Ann Neurol       Date:  2000-02       Impact factor: 10.422

8.  Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease.

Authors:  M Neystat; T Lynch; S Przedborski; N Kholodilov; M Rzhetskaya; R E Burke
Journal:  Mov Disord       Date:  1999-05       Impact factor: 10.338

9.  Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

Authors:  E Masliah; E Rockenstein; I Veinbergs; M Mallory; M Hashimoto; A Takeda; Y Sagara; A Sisk; L Mucke
Journal:  Science       Date:  2000-02-18       Impact factor: 47.728

10.  Choreoathetoid movements in cocaine dependence.

Authors:  G Bartzokis; M Beckson; D A Wirshing; P H Lu; J A Foster; J Mintz
Journal:  Biol Psychiatry       Date:  1999-06-15       Impact factor: 13.382

View more
  36 in total

1.  Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.

Authors:  Kavita Prasad; Elizabeth Tarasewicz; Pamela A Ohman Strickland; Michael O'Neill; Stephen N Mitchell; Kalpana Merchant; Samnang Tep; Kathryn Hilton; Akash Datwani; Manuel Buttini; Sarah Mueller-Steiner; Eric K Richfield
Journal:  Eur J Neurosci       Date:  2011-01-28       Impact factor: 3.386

2.  Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy.

Authors:  Changyoun Kim; Edward Rockenstein; Brian Spencer; Hyung-Koo Kim; Anthony Adame; Margarita Trejo; Klodjan Stafa; He-Jin Lee; Seung-Jae Lee; Eliezer Masliah
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

3.  Regulation of genes involved in dopamine transporter modulation by acute cocaine in rat striatum.

Authors:  Cindie Courtin; Dominique Crete; Corinne Canestrelli; Florence Noble; Cynthia Marie-Claire
Journal:  Neurosci Lett       Date:  2006-02-03       Impact factor: 3.046

4.  Expression of transcripts for myelin related genes in postmortem brain from cocaine abusers.

Authors:  Lars V Kristiansen; Michael J Bannon; James H Meador-Woodruff
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

5.  Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study.

Authors:  Sanjay Kasture; Stefania Vinci; Federico Ibba; Alessandro Puddu; Mara Marongiu; Balasubramanian Murali; Augusta Pisanu; Daniele Lecca; Gerald Zernig; Elio Acquas
Journal:  Neurotox Res       Date:  2009-06-24       Impact factor: 3.911

6.  Alpha-synuclein deletion decreases motor impulsivity but does not affect risky decision making in a mouse Gambling Task.

Authors:  Yolanda Peña-Oliver; Sandra Sanchez-Roige; David N Stephens; Tamzin L Ripley
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

Review 7.  Substance of abuse and movement disorders: complex interactions and comorbidities.

Authors:  Andres Deik; Rachel Saunders-Pullman; Marta San Luciano
Journal:  Curr Drug Abuse Rev       Date:  2012-09

8.  Genetic variation in the alpha synuclein gene (SNCA) is associated with BOLD response to alcohol cues.

Authors:  Claire E Wilcox; Eric D Claus; Sara K Blaine; Marilee Morgan; Kent E Hutchison
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

Review 9.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.